* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
A06001 | Agouti-related Protein (AGRP) [Tyr0] (25-51) , human | 3057.68 | C139H230N38O37S1 | Inquiry |
A06002 | Agouti-related Protein (AGRP) [Tyr0] (54-82), human | 3445.73 | C146H234N40O56 | Inquiry |
A06003 | Agouti-related Protein (AGRP) (25-82), human | 6415.39 | C279H468N80O90S1 | Inquiry |
A06004 | AGRP (25-51) | 2894.5 | Inquiry | |
A06005 | AGRP (54-82) | 3282.5 | Inquiry | |
A06006 | AGRP (87-132), human | 5202.2 | Inquiry | |
A06007 | AGRP fragment (83-132), amide | 5687.7 | Inquiry |
The agouti-related peptide (AgRP) is produced by AgRP/NPY neurons in the brain. AgRP and NPY are co-expressed to increase appetite and reduce metabolism and energy consumption. AgRP is a potent and long-lasting appetite stimulating substance encoded by the AgRP gene in human. AgRP is a paracrine signal molecule composed of 132 amino acids and is very stable to thermal denaturation and acid degradation. AgRP is mainly expressed in the hypothalamus and adrenal gland tissues, and is less expressed in the testis, kidney and lung.
It is reported that AgRP stimulates the hypothalamic-pituitary-adrenal axis to release adrenal cortex (ACTH), cortisol and prolactin. And AgRP also increases the response of adrenocortical hormone to IL-1β, suggesting that AgRP is involved in the regulation of neuroendocrine and the response to inflammation. AgRP is believed to be an inverse agonist of the melanocortin receptor, especially for MC3-R and MC4-R. The melanocortin receptors MC3-R and MC4-R are directly related to metabolism and body weight. These receptors are usually activated by melanocyte stimulating hormone (MSH) and inhibited by AgRP. MSH has an activation effect on most melanocortin receptors (except MC2-R), However, AgRP is only highly specific for MC3-R and MC4-R. This reverse agonism of AgRP not only has influence on MSH, but also reduces the produce of cAMP.
Accumulating evidence suggests that AgRP in the hypothalamus are essential for controlling energy balance. Therefore, AgRP is considered to be an important substance of energy balance so that scientists regard AgRP as a candidate gene for human obesity. There is also much evidence that AgRP has an inhibitory effect on the hypothalamic-pituitary-thyroid axis and inhibits hypothalamic thyroid stimulation of thyrotropin-releasing hormone expression to reduce thyroid hormone levels in the circulatory system. As AgRP plays an important role in energy metabolism, researchers spare much effort on the studies of AgRP for the treatment of some diseases like diabetes and obesity.
References
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Conotoxins are small peptides of 12 to 19 amino acids, which act as highly selective antagonists of ion channel ...
Pep2m, a peptide inhibitor of GluA2 subunit binding to NSF, reduces α-amino- 3-hydroxy-5-methyl-isoxazolepropion ...
MSG 606 (Cyclo-[(CH2) 3CO-Gly-His-D-Phe-Arg-D-Trp-Cys(S-)]-Asp-Arg-Phe-Gly-NH2) is a potent and novel cyclic thi ...
KAI-1678, a synthetic 21-amino acid, is a novel PKC-epsilon (ε-PKC) inhibitor with a molecular weight of 2541 Da ...
The cyclopentapeptide FC 131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-), 2-Nal=3-(2-naphthyl) alanine)) is an ...